Biotechnology
600 companies in this industry
Insider Buys (30d)
79
$10.08B
Insider Sells (30d)
200
$385.41M
Top Companies by Market Cap
VRTXVertex Pharmaceuticals Incorporated
$138.69BREGNRegeneron Pharmaceuticals, Inc.
$99.23BMRNAModerna, Inc.
$93.61BARGXargenx SE
$45.82BRVMDRevolution Medicines, Inc.
$39.08BROIVRoivant Sciences Ltd.
$28.64BINSMInsmed Incorporated
$26.58BUTHRUnited Therapeutics Corporation
$25.18BINCYIncyte Corporation
$24.66BBNTXBioNTech SE
$24.56BRecent Insider Trades
| Date | Ticker | Company | Insider | Role | Type | Shares | Avg Price | Value |
|---|---|---|---|---|---|---|---|---|
| Nov 16, 2026 | ABEO | Abeona Therapeutics Inc. | Charles Faith L. | director | Buy | 15,000 | $2.29 | $34.3K |
| Nov 16, 2026 | CRMD | CorMedix Inc. | Todisco Joseph | director, officer: Chief Executive Officer | Buy | 80,000 | $4.89 | $391.2K |
| Nov 16, 2026 | ZYME | Zymeworks Inc. | Moore Paul Andrew | officer: Chief Scientific Officer | Sell | 39,741 | $26.07 | $1.04M |
| Nov 16, 2026 | PHIO | Phio Pharmaceuticals Corp. | Deming David H | director | Buy | 12,000 | $0.82 | $9.8K |
| Nov 13, 2026 | CRVS | Corvus Pharmaceuticals, Inc. | Arcara Jeffrey | officer: Chief Business Officer | Buy | 4,500 | $11.22 | $50.5K |
| Nov 13, 2026 | ALDX | Aldeyra The | DOUGLAS RICHARD | director | Buy | 200,000 | $0.64 | $128.9K |
| Nov 13, 2026 | RVMD | Revolution Medicines, Inc. | Anders Jack | officer: Chief Financial Officer | Sell | 35,750 | $188.10 | $6.72M |
| Nov 13, 2026 | ALDX | Aldeyra The | Alfieri Michael | officer: Principal Financial Officer | Buy | 10,000 | $0.65 | $6.5K |
| Nov 13, 2026 | TNGX | Tango Therapeutics, Inc. | Crystal Adam | officer: President, R&D | Sell | 5,000 | $25.00 | $125.0K |
| Nov 13, 2026 | MIRM | Mirum Pharmaceuticals, Inc. | Brege Laura | director | Sell | 14,167 | $94.21 | $1.33M |
| Nov 13, 2026 | ALT | Altimmune, Inc. | Pisano Wayne | director | Buy | 10,000 | $1.64 | $16.4K |
| Nov 13, 2026 | XBIT | XBiotech Inc. | SIMARD JOHN | director, 10 percent owner: | Buy | 70,000 | $2.05 | $143.4K |
| Nov 13, 2026 | MANE | Veradermics, Incorporated | ENRIGHT PATRICK G | director | Sell | 250,000 | $150.38 | $37.59M |
| Nov 13, 2026 | CCCC | C4 Therapeutics, Inc. | Adams Kendra | officer: Chief Financial Officer | Sell | 45,173 | $2.71 | $122.5K |
| Nov 13, 2026 | ADPT | Adaptive Biotechnologies Corporation | RUBINSTEIN JULIE | officer: President and COO | Sell | 35,228 | $29.73 | $1.05M |
| Nov 13, 2026 | NXTC | NextCure, Inc. | ADAR1 Capital Management, LLC | 10 percent owner | Buy | 12,333 | $5.10 | $62.9K |
| Nov 13, 2026 | NTHI | Neonc Technologies Holdings, Inc. | Heshmatpour Amir F | director, 10 percent owner, officer: CEO, President | Buy | 30,000 | $5.02 | $150.5K |
| Nov 13, 2026 | SEPN | Septerna Inc | Ezekowitz Alan | director | Sell | 81,820 | $48.09 | $3.93M |
| Nov 13, 2026 | ORKA | Oruka Therapeutics, Inc. | Agarwal Arjun | officer: Senior Vice President, Finance | Sell | 10,000 | $104.97 | $1.05M |
| Nov 13, 2026 | MANE | Veradermics, Incorporated | Longitude Capital Partners V, LLC | 10 percent owner | Sell | 250,000 | $150.38 | $37.59M |
| Nov 13, 2026 | LPCN | Lipocine Inc. | Patel Mahesh V. | director, officer: Chief Executive Officer | Buy | 50,000 | $1.59 | $79.5K |
| Nov 13, 2026 | PBYI | Puma Biotechnology, Inc. | MILLER MICHAEL PATRICK | director | Sell | 15,000 | $8.10 | $121.5K |
| Nov 13, 2026 | ADPT | Adaptive Biotechnologies Corporation | BOBULSKY SUSAN | officer: Chief Commercial Officer, MRD | Sell | 1,875 | $32.00 | $60.0K |
| Nov 13, 2026 | UTHR | United Therapeutics Corporation | ROTHBLATT MARTINE A | director, officer: Chairperson & CEO | Sell | 9,500 | $593.52 | $5.64M |
| Nov 13, 2026 | KRRO | Korro Bio, Inc. | FORMELA JEAN FRANCOIS | director | Sell | 66,632 | $14.61 | $973.6K |
| Nov 13, 2026 | ORKA | Oruka Therapeutics, Inc. | BALL KRISTINE M | director | Sell | 18,000 | $104.93 | $1.89M |
| Nov 13, 2026 | EDIT | Editas Medicine, Inc. | Burkly Linda | officer: EVP, CHIEF SCIENTIFIC OFFICER | Sell | 7,814 | $2.42 | $18.9K |
| Nov 13, 2026 | AIM | AIM ImmunoTech Inc. | Equels Thomas K | director, officer: CEO & President | Buy | 35,000 | $0.15 | $5.2K |
| Nov 13, 2026 | PCVX | Vaxcyte, Inc. | Dhaliwal Harpreet S. | officer: Chief Technical Ops Officer | Sell | 17,000 | $67.83 | $1.15M |
| Nov 13, 2026 | ALT | Altimmune, Inc. | Durso Jerome Benedict | director, officer: President and CEO | Buy | 30,700 | $1.62 | $49.7K |
| Nov 13, 2026 | IONS | Ionis Pharmaceuticals, Inc. | Hayden Michael R | director | Buy | 5,000 | $29.64 | $148.2K |
| Nov 13, 2026 | ALT | Altimmune, Inc. | WEAVER GREGORY L | officer: Chief Financial Officer | Buy | 10,000 | $1.62 | $16.2K |
| Nov 13, 2026 | TXG | 10x Genomics, Inc. | Saxonov Serge | director, officer: Chief Executive Officer | Sell | 31,000 | $62.90 | $1.95M |
| Nov 13, 2026 | EDIT | Editas Medicine, Inc. | O'Neill Gilmore Neil | director, officer: CEO | Sell | 21,164 | $2.42 | $51.1K |
| Nov 12, 2026 | NTHI | Neonc Technologies Holdings, Inc. | CHEN THOMAS C | director, 10 percent owner, officer: CMO | Buy | 5,016 | $3.99 | $20.0K |
| Nov 12, 2026 | NTHI | Neonc Technologies Holdings, Inc. | Heshmatpour Amir F | director, 10 percent owner, officer: CEO, President | Buy | 60,000 | $4.16 | $249.6K |
| Nov 12, 2026 | AIM | AIM ImmunoTech Inc. | Equels Thomas K | director, officer: CEO & President | Buy | 39,000 | $0.14 | $5.4K |
| Nov 12, 2026 | TNXP | Tonix Pharmaceuticals Holding Corp. | LEDERMAN SETH | director, officer: Chief Executive Officer | Buy | 5,000 | $4.06 | $20.3K |
| Nov 12, 2026 | PHIO | Phio Pharmaceuticals Corp. | Deming David H | director | Buy | 12,000 | $0.84 | $10.1K |
| Nov 12, 2026 | MBX | MBX Biosciences, Inc. Common Stock | Hoerter Steven L. | director, officer: Chairman, President and CEO | Sell | 4,893 | $54.82 | $268.2K |
| Nov 12, 2026 | LYEL | Lyell Immunopharma, Inc. | Hill Stephen J. | officer: Chief Operating Officer | Sell | 88 | $15.93 | $1.4K |
| Nov 12, 2026 | ALNY | Alnylam Pharmaceuticals, Inc. | SCHULMAN AMY W | director | Buy | 1,910 | $156.82 | $299.5K |
| Nov 12, 2026 | AMLX | Amylyx Pharmaceuticals, Inc. | Cohen Joshua B | director, officer: Co-Chief Executive Officer | Sell | 100,000 | $29.84 | $2.98M |
| Nov 12, 2026 | LYEL | Lyell Immunopharma, Inc. | Lee Gary K. | officer: Chief Scientific Officer | Sell | 129 | $15.93 | $2.1K |
| Nov 12, 2026 | LYEL | Lyell Immunopharma, Inc. | Seely Lynn | director, officer: President and CEO | Sell | 545 | $15.93 | $8.7K |
| Nov 12, 2026 | IRON | Disc Medicine, Inc. | Savage William Jacob | officer: Chief Medical Officer | Sell | 16,035 | $85.09 | $1.36M |
| Nov 12, 2026 | UTHR | United Therapeutics Corporation | ROTHBLATT MARTINE A | director, officer: Chairperson & CEO | Sell | 19,000 | $590.16 | $11.21M |
| Nov 12, 2026 | OBIO | Orchestra BioMed Holdings, Inc. | RTW INVESTMENTS, LP | 10 percent owner | Buy | 1,200,000 | $5.00 | $6.00M |
| Nov 12, 2026 | LRMR | Larimar Therapeutics, Inc. | BEN-MAIMON CAROLE | director, officer: President and CEO | Buy | 18,050 | $2.77 | $50.0K |
| Nov 12, 2026 | RVMD | Revolution Medicines, Inc. | Mancini Anthony | officer: See Remarks | Sell | 811 | $200.00 | $162.2K |
Showing 1–50 of 279
1 / 6
...